Part 3 - GOOD COMPOUNDING PRACTICES FOR STERILE PREPARATIONS
- Section 535:15-10-50 - Purpose
- Section 535:15-10-51 - Definitions
- Section 535:15-10-52 - Pharmacist responsibilities
- Section 535:15-10-53 - General requirements
- Section 535:15-10-54 - CSP microbial contamination risk levels
- Section 535:15-10-55 - Drug compounding facilities
- Section 535:15-10-56 - Compounding equipment
- Section 535:15-10-57 - Component selection requirements
- Section 535:15-10-58 - Control of drug product containers
- Section 535:15-10-59 - Drug compounding controls
- Section 535:15-10-60 - Transfer of sterile compounded prescriptions
- Section 535:15-10-61 - Beyond use dating (BUD)
- Section 535:15-10-62 - Labeling
- Section 535:15-10-63 - Records and reports
- Section 535:15-10-64 - Compounding for institution and/or practitioner administration [Revoked]
- Section 535:15-10-64.1 - Compounding veterinarian sterile preparations
- Section 535:15-10-65 - Compounding of sterile hazardous drugs
- Section 535:15-10-66 - [Revoked]
- Section 535:15-10-67 - Compounding of sterile allergen extracts
- Section 535:15-10-68 - Violations